The Bitrack surgical robot has completed its technical validation at Specipig

News

The new Bitrack System robot for minimally invasive laparoscopy surgery, developed by the company Rob Surgical, has successfully completed its technical validation in the new experimental operating room at Specipig.

Bitrack is the modular, flexible and more economical alternative to the American Da Vinci robot installed in many leading hospitals around the world. It is preparing for European authorisation and to enter the market by 2019.

The trials using the final prototype were conducted in Specipig as a preclinical CRO with GLP certification specialising in medical device testing with pig model. The trials involved surgeons specialising in surgical robotics with knowledge of the Da Vinci system, including Dr Javier Magriña, Mayo Clinic surgeon. The technical management of the project was the responsibility of Dr Josep Amat, academic at the Universitat Politècnica de Catalunya and head of robotics at the Research Centre for Biomedical Engineering (CREB).